Рет қаралды 4,132
I spoke Alex Moussa, Senior Vice President and General Manager for EMEA at Dexcom about all updates from Dexcom during EASD. Key news included an important study showing advantages of using CGM for 7-years- I am sure it comes as no surprise to all of you that CGM gives sustained benefit- lets hope this new data persuades all policy bodies and funding organisations too.
In terms of product, we (finally) have our first AID integration timelines for Dexcom G7. ControlIQ is rolling out support for G7 in a number of European countries by the end of the year. More in the video.
Let me know if you have any questions below.
0:00 Intro
1:16 Dexcom G7 AID timings
4:45 Dexcom One Announcements
7:16 Environmental Commitments
10:35 Direct to Watch
*******************************************
My email address: nerdabetic@gmail.com
My Instagram: / nerdabetic
My Twitter: / nerdabetic
*******************************************